# DESCRIPTION

## FIELD OF THE DISCLOSURE

## BACKGROUND

## BRIEF SUMMARY OF THE DISCLOSURE

## DETAILED DESCRIPTION

### I. Definitions

### II. Complement Component Binding Molecules

### III. Target Antigen Binding Molecules

### IV. Bispecific Antigen-Binding Molecules

### Sequence Variants

### Bioequivalents

### V. Therapeutic Formulation and Administration

### VI. Therapeutic Uses of the Antigen-Binding Molecules

## EXAMPLES

### Example 1. Preparation of Anti-C1q Antibodies

### Example 2. Preparation of Anti-IsdB Antibodies

### Example 3. Preparation of Anti-CD20 Antibodies

### Example 4. Preparation of Anti-Influenza HA Antibodies

### Example 5. Preparation of Anti-GITR Antibodies

### Example 6. Preparation of Anti-Ps1 Antibodies

### Example 7: Preparation of Anti-Protein A Antibodies

### Example 8: Preparation of Anti-IsdA Antibodies

### Example 9. Preparation of Anti-Poly-N-Acetylglucosamine (PNAG)

